Accelerate Diagnostics AXDX reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Accelerate Diagnostics missed estimated earnings by -44.0%, reporting an EPS of $-0.89 versus an estimate of $-0.62.
Revenue was up $55 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11 which was followed by a 3.0% drop in the share price the next day.
Here's a look at Accelerate Diagnostics's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -1.07 | -1.40 | -1.4 | -1.5 |
EPS Actual | -1.18 | -1.31 | -1.7 | -1.5 |
Revenue Estimate | 3.53M | 3.60M | 3.35M | 2.87M |
Revenue Actual | 3.30M | 2.92M | 2.81M | 2.97M |
To track all earnings releases for Accelerate Diagnostics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.